Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Industry News

BIOMODEX Technology Enables New Milestone in Interventional Cardiology

July 21, 2021

News Industry News

Abbott Announces European Approval Of Two Life-Saving Heart Devices For Babies And Children

September 17, 2019

News Industry News

NobleStitch™ EL Receives Approval Of IDE To Conduct A Trial For Reduction Of Recurrent Ischemic Stroke

September 05, 2019

News Industry News

Initial Results of LAA Closure Device for Stroke Prevention in Patients with Atrial Fibrillation Demonstrate Device Safety and Low Rates of Major Adverse Events

November 02, 2016

News Industry News TCT 2016

Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke

November 01, 2016

News Industry News

St. Jude Medical Launches Global Clinical Trial to Evaluate a New Therapy Option for Patients at an Increased Risk of Stroke Due to Atrial Fibrillation

September 01, 2016

News Industry News

Long-Term Study Results Show That PFO Closure May Be Effective In Preventing Recurrent Cryptogenic Stroke, Particularly In Younger Patients

October 15, 2015

News Industry News

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

October 28, 2013

News Industry News

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

May 17, 2013

News Industry News

Data from St. Jude Medical RESPECT Trial for PFO Closure Highlighted at International Stroke Conference 2013

February 07, 2013

News Industry News

St. Jude Medical Receives CE Mark of Next-Generation Cardiac Device for Stroke Prevention

January 17, 2013

News Industry News

Gore Reacts to RESPECT Trial Results

October 26, 2012

News Industry News

St. Jude Medical RESPECT Trial for PFO Closure Provides Clinical Evidence of Risk Reduction in Prevention of Recurrent Cryptogenic Stroke

October 25, 2012

News Industry News

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

October 25, 2012

News Industry News

Clinical Trial Shows that PFO Closure With Investigational Device Does Not Decrease Ischemic and Bleeding Events Compared to Medical Therapy

October 25, 2012

News Industry News

St. Jude Medical Announces FDA Clearance of the AMPLATZER Vascular Plug 4

June 18, 2012

News Industry News

Key Clinical Data for St. Jude Medical’s Structural Heart Technologies Revealed at EuroPCR

May 16, 2012

News Industry News

St. Jude Medical to Showcase PCI Optimization Technology and Structural Heart Portfolio at EuroPCR

May 16, 2011

Advertisement

BIOMODEX Technology Enables New Milestone in Interventional Cardiology

Abbott Announces European Approval Of Two Life-Saving Heart Devices For Babies And Children

NobleStitch™ EL Receives Approval Of IDE To Conduct A Trial For Reduction Of Recurrent Ischemic Stroke

Initial Results of LAA Closure Device for Stroke Prevention in Patients with Atrial Fibrillation Demonstrate Device Safety and Low Rates of Major Adverse Events

Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke

St. Jude Medical Launches Global Clinical Trial to Evaluate a New Therapy Option for Patients at an Increased Risk of Stroke Due to Atrial Fibrillation

Long-Term Study Results Show That PFO Closure May Be Effective In Preventing Recurrent Cryptogenic Stroke, Particularly In Younger Patients

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

Data from St. Jude Medical RESPECT Trial for PFO Closure Highlighted at International Stroke Conference 2013

St. Jude Medical Receives CE Mark of Next-Generation Cardiac Device for Stroke Prevention

Gore Reacts to RESPECT Trial Results

St. Jude Medical RESPECT Trial for PFO Closure Provides Clinical Evidence of Risk Reduction in Prevention of Recurrent Cryptogenic Stroke

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

Clinical Trial Shows that PFO Closure With Investigational Device Does Not Decrease Ischemic and Bleeding Events Compared to Medical Therapy

St. Jude Medical Announces FDA Clearance of the AMPLATZER Vascular Plug 4

Key Clinical Data for St. Jude Medical’s Structural Heart Technologies Revealed at EuroPCR

St. Jude Medical to Showcase PCI Optimization Technology and Structural Heart Portfolio at EuroPCR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content